{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,10]],"date-time":"2026-04-10T10:19:18Z","timestamp":1775816358846,"version":"3.50.1"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,2,4]],"date-time":"2026-02-04T00:00:00Z","timestamp":1770163200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T00:00:00Z","timestamp":1774483200000},"content-version":"vor","delay-in-days":50,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"the Guiding Project of the Science and Technology Department of Fujian Province","award":["2023D018"],"award-info":[{"award-number":["2023D018"]}]},{"name":"Seventh Batch of National Academic Experience Inheritance Projects for Senior Traditional Chinese Medicine Experts","award":["National Traditional Chinese Medicine Education Letter [2022] No. 76"],"award-info":[{"award-number":["National Traditional Chinese Medicine Education Letter [2022] No. 76"]}]},{"name":"Jinglu Talent Program"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Gastroenterol"],"DOI":"10.1186\/s12876-026-04645-4","type":"journal-article","created":{"date-parts":[[2026,2,4]],"date-time":"2026-02-04T06:33:49Z","timestamp":1770186829000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Diagnostic value of LPRI for assessing advanced liver fibrosis in patients with chronic hepatitis B and non-alcoholic fatty liver disease"],"prefix":"10.1186","volume":"26","author":[{"given":"Min","family":"Wang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huaxiao","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiaen","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xueting","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Runyan","family":"He","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Baohui","family":"Pei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaolu","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yanneng","family":"Kang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Longhao","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,2,4]]},"reference":[{"issue":"2","key":"4645_CR1","doi-asserted-by":"publisher","first-page":"382","DOI":"10.3350\/cmh.2024.0987","volume":"31","author":"D Kim","year":"2025","unstructured":"Kim D, Danpanichkul P, Wijarnpreecha K, Cholankeril G, Loomba R, Ahmed A. Current burden of steatotic liver disease and fibrosis among adults in the united States, 2017\u20132023. Clin Mol Hepatol. 2025;31(2):382\u201393.","journal-title":"Clin Mol Hepatol"},{"issue":"10","key":"4645_CR2","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1016\/S2468-1253(23)00197-8","volume":"8","author":"Polaris Observatory Collaborators","year":"2023","unstructured":"Polaris Observatory Collaborators. Global prevalence, cascade of care, and prophylaxis coverage of hepatitis B in 2022: a modelling study. Lancet Gastroenterol Hepatol. 2023;8(10):879\u2013907.","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"9","key":"4645_CR3","doi-asserted-by":"publisher","first-page":"1100","DOI":"10.1111\/apt.16595","volume":"54","author":"Q Zheng","year":"2021","unstructured":"Zheng Q, Zou B, Wu Y, et al. Systematic review with meta-analysis: prevalence of hepatic steatosis, fibrosis and associated factors in chronic hepatitis B. Aliment Pharmacol Ther. 2021;54(9):1100\u20139.","journal-title":"Aliment Pharmacol Ther"},{"issue":"10","key":"4645_CR4","doi-asserted-by":"publisher","first-page":"1476","DOI":"10.1016\/j.jfma.2020.05.027","volume":"119","author":"HJ Su","year":"2020","unstructured":"Su HJ, Kao JH, Tseng TC, et al. Pathologic findings of patients with nonalcoholic fatty liver disease and the impact of concurrent hepatitis B virus infection in Taiwan. J Formos Med Assoc. 2020;119(10):1476\u201382.","journal-title":"J Formos Med Assoc"},{"issue":"10","key":"4645_CR5","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1111\/jvh.13872","volume":"30","author":"R Zhou","year":"2023","unstructured":"Zhou R, Yang L, Zhang B, et al. Clinical impact of hepatic steatosis on chronic hepatitis B patients in asia: A systematic review and meta-analysis. J Viral Hepat. 2023;30(10):793\u2013802.","journal-title":"J Viral Hepat"},{"issue":"2","key":"4645_CR6","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1002\/hep.30857","volume":"71","author":"HSJ Choi","year":"2020","unstructured":"Choi HSJ, Brouwer WP, Zanjir WMR, et al. Nonalcoholic steatohepatitis is associated with liver-related outcomes and all-cause mortality in chronic hepatitis B. Hepatology. 2020;71(2):539\u201348.","journal-title":"Hepatology"},{"issue":"2","key":"4645_CR7","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1053\/jhep.2003.50346","volume":"38","author":"CT Wai","year":"2003","unstructured":"Wai CT, Greenson JK, Fontana RJ, et al. A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C. Hepatology. 2003;38(2):518\u201326.","journal-title":"Hepatology"},{"issue":"6","key":"4645_CR8","doi-asserted-by":"publisher","first-page":"1317","DOI":"10.1002\/hep.21178","volume":"43","author":"RK Sterling","year":"2006","unstructured":"Sterling RK, Lissen E, Clumeck N, et al. Development of a simple noninvasive index to predict significant fibrosis in patients with HIV\/HCV coinfection. Hepatology. 2006;43(6):1317\u201325.","journal-title":"Hepatology"},{"key":"4645_CR9","doi-asserted-by":"publisher","first-page":"1481051","DOI":"10.3389\/fmed.2024.1481051","volume":"11","author":"X Fang","year":"2024","unstructured":"Fang X, Yin Y, Zhao H, et al. Effect of fatty liver disease on liver function and fibrosis in patients with chronic hepatitis B: a cross-sectional study. Front Med (Lausanne). 2024;11:1481051.","journal-title":"Front Med (Lausanne)"},{"issue":"1","key":"4645_CR10","doi-asserted-by":"publisher","first-page":"2420858","DOI":"10.1080\/07853890.2024.2420858","volume":"56","author":"Y Tan","year":"2024","unstructured":"Tan Y, Zhang X. Diagnostic accuracy of FibroScan-AST (FAST) score, non-alcoholic fatty liver fibrosis score (NFS), FibroScan, and liver fibrosis index (FIB-4) for identifying fibrotic non-alcoholic steatohepatitis in patients with chronic hepatitis B with metabolic dysfunction-associated fatty liver disease. Ann Med. 2024;56(1):2420858.","journal-title":"Ann Med"},{"issue":"4","key":"4645_CR11","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1016\/S2468-1253(24)00437-0","volume":"10","author":"A Liguori","year":"2025","unstructured":"Liguori A, Zoncap\u00e8 M, Casazza G, Easterbrook P, Tsochatzis EA. Staging liver fibrosis and cirrhosis using non-invasive tests in people with chronic hepatitis B to inform WHO 2024 guidelines: a systematic review and meta-analysis. Lancet Gastroenterol Hepatol. 2025;10(4):332\u201349.","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"3","key":"4645_CR12","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1016\/j.jhep.2021.05.025","volume":"75","author":"European Association for the Study of the Liver (EASL)","year":"2021","unstructured":"European Association for the Study of the Liver (EASL). EASL clinical practice guidelines on non-invasive tests for evaluation of liver disease severity and prognosis \u2013\u20092021 update. J Hepatol. 2021;75(3):659\u201389.","journal-title":"J Hepatol"},{"issue":"10","key":"4645_CR13","doi-asserted-by":"publisher","first-page":"e70071","DOI":"10.1111\/jvh.70071","volume":"32","author":"RT Natour","year":"2025","unstructured":"Natour RT, Haimi M, Hazan R, Saadi T, Baker FA. Reduced predictive performance of the FIB-4 index in chronic hepatitis b patients with concurrent metabolic dysfunction-associated liver disease. J Viral Hepat. 2025;32(10):e70071.","journal-title":"J Viral Hepat"},{"issue":"1","key":"4645_CR14","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1186\/s13244-024-01857-8","volume":"15","author":"Z Chen","year":"2024","unstructured":"Chen Z, Huang Y, Zhang Y, et al. Impact of hepatic steatosis on liver stiffness measurement by vibration-controlled transient elastography and its diagnostic performance for identifying liver fibrosis in patients with chronic hepatitis B. Insights Imaging. 2024;15(1):283.","journal-title":"Insights Imaging"},{"issue":"8","key":"4645_CR15","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1111\/hepr.12793","volume":"47","author":"A Okajima","year":"2017","unstructured":"Okajima A, Sumida Y, Taketani H, et al. Liver stiffness measurement to platelet ratio index predicts the stage of liver fibrosis in non-alcoholic fatty liver disease. Hepatol Res. 2017;47(8):721\u201330.","journal-title":"Hepatol Res"},{"key":"4645_CR16","doi-asserted-by":"crossref","unstructured":"Zhang S, Cui F. Global progress, challenges and strategies in eliminating public threat of viral\u00a0hepatitis. Infect Dis Poverty. 2025;14(1):9.","DOI":"10.1186\/s40249-025-01275-y"},{"key":"4645_CR17","unstructured":"National Workshop on Fatty Liver and Alcoholic\u00a0Liver Disease, Chinese Society of Hepatology, Chinese Medical Association; Fatty Liver Expert\u00a0Committee, Chinese Medical Doctor Association. Guidelines of prevention and treatment for\u00a0nonalcoholic fatty liver disease: a 2018 update. Chin J Hepatol. 2018;26(3):195\u2013203."},{"issue":"3","key":"4645_CR18","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1111\/j.1572-0241.2005.41289.x","volume":"100","author":"AY Hui","year":"2005","unstructured":"Hui AY, Chan HL, Wong VW, et al. Identification of chronic hepatitis B patients without significant liver fibrosis by a simple noninvasive predictive model. Am J Gastroenterol. 2005;100(3):616\u201323.","journal-title":"Am J Gastroenterol"},{"issue":"3","key":"4645_CR19","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1016\/0168-8278(91)90084-O","volume":"13","author":"PJ Scheuer","year":"1991","unstructured":"Scheuer PJ. Classification of chronic viral hepatitis: a need for reassessment. J Hepatol. 1991;13(3):372\u20134.","journal-title":"J Hepatol"},{"key":"4645_CR20","doi-asserted-by":"publisher","first-page":"965548","DOI":"10.3389\/fimmu.2022.965548","volume":"13","author":"E Tourkochristou","year":"2022","unstructured":"Tourkochristou E, Assimakopoulos SF, Thomopoulos K, Marangos M, Triantos C. NAFLD and HBV interplay - related mechanisms underlying liver disease progression. Front Immunol. 2022;13:965548.","journal-title":"Front Immunol"},{"issue":"9","key":"4645_CR21","doi-asserted-by":"publisher","first-page":"1787","DOI":"10.1093\/cvr\/cvad095","volume":"119","author":"C Grander","year":"2023","unstructured":"Grander C, Grabherr F, Tilg H. Non-alcoholic fatty liver disease: pathophysiological concepts and treatment options. Cardiovasc Res. 2023;119(9):1787\u201398.","journal-title":"Cardiovasc Res"},{"issue":"1","key":"4645_CR22","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1111\/liv.15116","volume":"42","author":"YP Mendoza","year":"2022","unstructured":"Mendoza YP, Rodrigues SG, Delgado MG, et al. Inflammatory activity affects the accuracy of liver stiffness measurement by transient elastography but not by two-dimensional shear wave elastography in non-alcoholic fatty liver disease. Liver Int. 2022;42(1):102\u201311.","journal-title":"Liver Int"},{"issue":"7","key":"4645_CR23","doi-asserted-by":"publisher","first-page":"e23270","DOI":"10.1002\/jcla.23270","volume":"34","author":"LK Zhong","year":"2020","unstructured":"Zhong LK, Zhang G, Luo SY, Yin W, Song HY. The value of platelet count in evaluating the degree of liver fibrosis in patients with chronic hepatitis B. J Clin Lab Anal. 2020;34(7):e23270.","journal-title":"J Clin Lab Anal"},{"key":"4645_CR24","doi-asserted-by":"crossref","unstructured":"Huang H, Bai Y, Zhao Y, Sun X. Differential association of platelet indices in NAFLD\/NASH: a Mendelian randomized study. Eur J Gastroenterol Hepatol. 2025;37(12):1360\u20139.","DOI":"10.1097\/MEG.0000000000003029"},{"issue":"109","key":"4645_CR25","doi-asserted-by":"publisher","first-page":"1321","DOI":"10.5754\/hge11041","volume":"58","author":"JJ Park","year":"2011","unstructured":"Park JJ, Park JY, Kim DY, et al. Prediction of significant fibrosis in chronic hepatitis C patients with normal ALT. Hepatogastroenterology. 2011;58(109):1321\u20137.","journal-title":"Hepatogastroenterology"},{"issue":"09","key":"4645_CR26","first-page":"2110","volume":"39","author":"B Huang","year":"2023","unstructured":"Huang B, Ou L, Zhang Y, et al. Value of traditional noninvasive fibrosis models in diagnosis of significant liver fibrosis in patients with chronic hepatitis B and metabolic associated fatty liver disease. J Clin Hepatol. 2023;39(09):2110\u20136. (in Chinese).","journal-title":"J Clin Hepatol"},{"issue":"11","key":"4645_CR27","doi-asserted-by":"publisher","first-page":"2250","DOI":"10.1016\/j.cgh.2024.06.014","volume":"22","author":"F Rui","year":"2024","unstructured":"Rui F, Xu L, Yeo YH, et al. Machine learning-based models for advanced fibrosis and cirrhosis diagnosis in chronic hepatitis B patients with hepatic steatosis. Clin Gastroenterol Hepatol. 2024;22(11):2250\u2013e6012.","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"4","key":"4645_CR28","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1111\/jvh.13808","volume":"30","author":"J Wang","year":"2023","unstructured":"Wang J, Huang R, Liu J, et al. A novel non-invasive model for the prediction of advanced liver fibrosis in chronic hepatitis B patients with NAFLD. J Viral Hepat. 2023;30(4):287\u201396.","journal-title":"J Viral Hepat"},{"issue":"10","key":"4645_CR29","doi-asserted-by":"publisher","first-page":"2229","DOI":"10.3390\/biomedicines12102229","volume":"12","author":"K Somnay","year":"2024","unstructured":"Somnay K, Wadgaonkar P, Sridhar N, Roshni P, Rao N, Wadgaonkar R. Liver fibrosis leading to cirrhosis: basic mechanisms and clinical perspectives. Biomedicines. 2024;12(10):2229.","journal-title":"Biomedicines"},{"issue":"4","key":"4645_CR30","doi-asserted-by":"publisher","first-page":"2376","DOI":"10.21037\/qims-22-831","volume":"13","author":"L Song","year":"2023","unstructured":"Song L, Zhao L, Deng J, et al. Staging liver fibrosis in patients with chronic hepatitis B using two-dimensional shear wave elastography based on histopathological findings: a prospective multicenter study. Quant Imaging Med Surg. 2023;13(4):2376\u201387.","journal-title":"Quant Imaging Med Surg"}],"container-title":["BMC Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12876-026-04645-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12876-026-04645-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12876-026-04645-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T10:18:27Z","timestamp":1774520307000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12876-026-04645-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,4]]},"references-count":30,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4645"],"URL":"https:\/\/doi.org\/10.1186\/s12876-026-04645-4","relation":{},"ISSN":["1471-230X"],"issn-type":[{"value":"1471-230X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,4]]},"assertion":[{"value":"25 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was conducted in accordance with the ethical principles of the Declaration of Helsinki. The study protocol was approved by the Ethics Committee of Xiamen Hospital of Traditional Chinese Medicine (Approval No. 2025-X075-01). The requirement for informed consent was waived by the Ethics Committee because this study involved the retrospective analysis of anonymized clinical data and obtaining consent from each participant was not feasible.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"191"}}